Parag Mahale

1.9k total citations
56 papers, 1.1k citations indexed

About

Parag Mahale is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Parag Mahale has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hepatology, 27 papers in Epidemiology and 18 papers in Oncology. Recurrent topics in Parag Mahale's work include Hepatitis C virus research (31 papers), Liver Disease Diagnosis and Treatment (16 papers) and Viral-associated cancers and disorders (14 papers). Parag Mahale is often cited by papers focused on Hepatitis C virus research (31 papers), Liver Disease Diagnosis and Treatment (16 papers) and Viral-associated cancers and disorders (14 papers). Parag Mahale collaborates with scholars based in United States, China and Uganda. Parag Mahale's co-authors include Harrys A. Torres, Eric A. Engels, Ying Jiang, Meredith S. Shiels, Jeff Hosry, Jennifer R. Kramer, Ruosha Li, Eric L. Brown, Minas P. Economides and Anna E. Coghill and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Parag Mahale

54 papers receiving 1.1k citations

Peers

Parag Mahale
Nicholas Jabbour United States
Benjamin Emmanuel United States
D. Lacoste France
C Pellet France
M. Fasano Italy
Shehnaz K. Hussain United States
Mathew Simcock Switzerland
Caroline Dickens South Africa
Nicholas Jabbour United States
Parag Mahale
Citations per year, relative to Parag Mahale Parag Mahale (= 1×) peers Nicholas Jabbour

Countries citing papers authored by Parag Mahale

Since Specialization
Citations

This map shows the geographic impact of Parag Mahale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parag Mahale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parag Mahale more than expected).

Fields of papers citing papers by Parag Mahale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parag Mahale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parag Mahale. The network helps show where Parag Mahale may publish in the future.

Co-authorship network of co-authors of Parag Mahale

This figure shows the co-authorship network connecting the top 25 collaborators of Parag Mahale. A scholar is included among the top collaborators of Parag Mahale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parag Mahale. Parag Mahale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patrick, Rudy, Parag Mahale, Bradley K. Ackerson, et al.. (2025). Respiratory syncytial virus vaccine uptake among adults aged ≥60 years in a large, integrated healthcare system in Southern California 2023–2024. Vaccine. 53. 127033–127033. 2 indexed citations
2.
Fischer, Heidi, Lei Qian, Zhuoxin Li, et al.. (2025). Development and validation of prediction algorithm to identify tuberculosis in two large California health systems. Nature Communications. 16(1). 3385–3385.
3.
Lewnard, Joseph A., Parag Mahale, Deborah E. Malden, et al.. (2024). Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineage. Nature Communications. 15(1). 8550–8550. 8 indexed citations
4.
Mahale, Parag, Ruth M. Pfeiffer, Ping Liu, et al.. (2023). Hepatitis B virus and hepatitis D virus infection in women with or at risk for HIV infection in the United States. Frontiers in Medicine. 10. 1070420–1070420. 1 indexed citations
5.
Fischer, Heidi, Lei Qian, Zhuoxin Li, et al.. (2023). Prior Screening for Latent Tuberculosis Among Patients Diagnosed With Tuberculosis Disease: Missed Opportunities?. Open Forum Infectious Diseases. 10(11). ofad545–ofad545. 1 indexed citations
6.
Mahale, Parag, Jason Nomburg, Joo Y. Song, et al.. (2021). Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphoma. Infectious Agents and Cancer. 16(1). 65–65. 1 indexed citations
7.
Liu, Zhiwei, Parag Mahale, & Eric A. Engels. (2018). Sepsis and Risk of Cancer Among Elderly Adults in the United States. Clinical Infectious Diseases. 68(5). 717–724. 42 indexed citations
8.
Triplette, Matthew, Kristina Crothers, Parag Mahale, et al.. (2018). Risk of lung cancer in lung transplant recipients in the United States. American Journal of Transplantation. 19(5). 1478–1490. 31 indexed citations
9.
Economides, Minas P., Moran Amit, Parag Mahale, et al.. (2017). Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer. Cancer. 124(5). 960–965. 6 indexed citations
10.
Mahale, Parag, Meredith S. Shiels, Charles F. Lynch, & Eric A. Engels. (2017). Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients. American Journal of Transplantation. 18(2). 453–461. 30 indexed citations
11.
Mahale, Parag, Eric A. Engels, Ruosha Li, et al.. (2017). The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection. Gut. 67(3). 553–561. 97 indexed citations
12.
Mahale, Parag, Erich M. Sturgis, David J. Tweardy, Ella Ariza‐Heredia, & Harrys A. Torres. (2016). Association Between Hepatitis C Virus and Head and Neck Cancers. JNCI Journal of the National Cancer Institute. 108(8). djw035–djw035. 50 indexed citations
13.
Torres, Harrys A., Parag Mahale, Minas P. Economides, et al.. (2016). Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center. Journal of the National Comprehensive Cancer Network. 14(9). 1185–1188. 2 indexed citations
14.
Couturier, Jacob, Miguel Ángel Medina, Petri Urvil, et al.. (2014). HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies. Virology. 462-463. 175–188. 12 indexed citations
15.
Torres, Harrys A., Ahmed O. Kaseb, Parag Mahale, Ethan Miller, & Catherine Frenette. (2014). Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series. SHILAP Revista de lepidopterología. 1. 109–109. 3 indexed citations
16.
Torres, Harrys A., Amit Saxena, Bruno Granwehr, et al.. (2014). Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Clinical Microbiology and Infection. 20(10). O672–O679. 41 indexed citations
17.
Kyvernitakis, Andreas, Thein Hlaing Oo, Michael H. Kroll, et al.. (2014). Incidence and Management of Hematological Toxicities Associated with Treatment of Hepatitis C Virus Infection in Cancer Patients. Blood. 124(21). 4126–4126. 1 indexed citations
18.
Mahale, Parag, Pablo C. Okhuysen, & Harrys A. Torres. (2013). Does Chemotherapy Cause Viral Relapse in Cancer Patients With Hepatitis C Infection Successfully Treated With Antivirals?. Clinical Gastroenterology and Hepatology. 12(6). 1051–1054.e1. 13 indexed citations
19.
Torres, Harrys A., Moises I. Nevah, Ben J. Barnett, et al.. (2012). Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: A retrospective multicenter study. Journal of Clinical Virology. 54(3). 218–222. 12 indexed citations
20.
Mahale, Parag, Dimitrios P. Kontoyiannis, Roy F. Chemaly, et al.. (2012). Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. Journal of Hepatology. 57(6). 1177–1185. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026